Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tocilizumab in patients with severe COVID-19: a retrospective cohort study.
Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M, Franceschini E, Cuomo G, Orlando G, Borghi V, Santoro A, Di Gaetano M, Puzzolante C, Carli F, Bedini A, Corradi L, Fantini R, Castaniere I, Tabbì L, Girardis M, Tedeschi S, Giannella M, Bartoletti M, Pascale R, Dolci G, Brugioni L, Pietrangelo A, Cossarizza A, Pea F, Clini E, Salvarani C, Massari M, Viale PL, Mussini C. Guaraldi G, et al. Among authors: pascale r. Lancet Rheumatol. 2020 Aug;2(8):e474-e484. doi: 10.1016/S2665-9913(20)30173-9. Epub 2020 Jun 24. Lancet Rheumatol. 2020. PMID: 32835257 Free PMC article.
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.
Bartoletti M, Tedeschi S, Pascale R, Raumer L, Maraolo AE, Palmiero G, Tumietto F, Cristini F, Ambretti S, Giannella M, Lewis RE, Viale P. Bartoletti M, et al. Among authors: pascale r. Int J Antimicrob Agents. 2018 Mar;51(3):516-521. doi: 10.1016/j.ijantimicag.2018.01.010. Epub 2018 Feb 2. Int J Antimicrob Agents. 2018. PMID: 29410250
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
Giannella M, Pascale R, Ferraro G, Toschi A, Pancaldi L, Furii F, Bartoletti M, Tedeschi S, Ambretti S, Lewis RE, Viale P. Giannella M, et al. Among authors: pascale r. Int J Antimicrob Agents. 2019 May;53(5):574-581. doi: 10.1016/j.ijantimicag.2019.01.005. Epub 2019 Jan 9. Int J Antimicrob Agents. 2019. PMID: 30639527
Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study.
Bartoletti M, Giannella M, Lewis RE, Caraceni P, Tedeschi S, Paul M, Schramm C, Bruns T, Merli M, Cobos-Trigueros N, Seminari E, Retamar P, Muñoz P, Tumbarello M, Burra P, Torrani Cerenzia M, Barsic B, Calbo E, Maraolo AE, Petrosillo N, Galan-Ladero MA, D'Offizi G, Zak-Doron Y, Rodriguez-Baño J, Baldassarre M, Verucchi G, Domenicali M, Bernardi M, Viale P; ESGBIS/BICHROME study group. Bartoletti M, et al. Clin Infect Dis. 2019 Oct 30;69(10):1731-1739. doi: 10.1093/cid/ciz032. Clin Infect Dis. 2019. PMID: 30649218 Free article.
Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.
Giannella M, Bussini L, Pascale R, Bartoletti M, Malagrinò M, Pancaldi L, Toschi A, Ferraro G, Marconi L, Ambretti S, Lewis R, Viale P. Giannella M, et al. Among authors: pascale r. Open Forum Infect Dis. 2019 Dec 12;6(12):ofz505. doi: 10.1093/ofid/ofz505. eCollection 2019 Dec. Open Forum Infect Dis. 2019. PMID: 31858018 Free PMC article.
238 results